Philip Janiak

Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats

Magali Gary‐Bobo, Ghizlane Elachouri, Jean François Gallas et al. · Hepatology · 2007 · 304 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Role of angiotensin subtype 2 receptor in neointima formation after vascular injury.

Philip Janiak, Arnaud Pillon, Jean‐François Prost et al. · Hypertension · 1992 · 216 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

The anti‐obesity effect of rimonabant is associated with an improved serum lipid profile

Bruno Poirier, Jean‐Pierre Bidouard, C. Cadrouvele et al. · Diabetes Obesity and Metabolism · 2004 · 200 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats

Philip Janiak, Bruno Poirier, Jean‐Pierre Bidouard et al. · Kidney International · 2007 · 121 citations · Full text

Medicine, Biochemistry, Pharmacology +11

PCSK9 Modulates the Secretion But Not the Cellular Uptake of Lipoprotein(a) Ex Vivo

Elise F. Villard, Aurélie Thedrez, Jörg Blankenstein et al. · JACC Basic to Translational Science · 2016 · 121 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17